JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,372,243 | -88.4% | 452,590 | -88.2% | 0.13% | -91.2% |
| Q1 2023 | $46,445,681 | +148.1% | 3,838,486 | +170.1% | 1.50% | +162.5% |
| Q4 2022 | $18,718,771 | -2.7% | 1,421,319 | 0.0% | 0.57% | +0.4% |
| Q3 2022 | $19,245,000 | +10.9% | 1,421,319 | 0.0% | 0.57% | -5.2% |
| Q2 2022 | $17,354,000 | -14.9% | 1,421,319 | 0.0% | 0.60% | -6.1% |
| Q1 2022 | $20,382,000 | -26.8% | 1,421,319 | +0.7% | 0.64% | -28.2% |
| Q4 2021 | $27,858,000 | -8.8% | 1,411,975 | 0.0% | 0.89% | -16.4% |
| Q3 2021 | $30,541,000 | -13.3% | 1,411,975 | 0.0% | 1.06% | -19.4% |
| Q2 2021 | $35,229,000 | – | 1,411,975 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |